AAAAAA
Results:
1-21
|
Results: 21
Authors:
Henry, PG
Dautry, C
Hantraye, P
Bloch, G
Citation: Pg. Henry et al., Brain GABA editing without macromolecule contamination, MAGN RES M, 45(3), 2001, pp. 517-520
Authors:
Poyot, T
Conde, F
Gregoire, MC
Frouin, V
Coulon, C
Fuseau, C
Hinnen, F
Dolle, F
Hantraye, P
Bottlaender, M
Citation: T. Poyot et al., Anatomic and biochemical correlates of the dopamine transporter ligand C-11-PE2I in normal and parkinsonian primates: Comparison with 6-[F-18] Fluoro-L-Dopa, J CEREBR B, 21(7), 2001, pp. 782-792
Authors:
Beal, MF
Hantraye, P
Citation: Mf. Beal et P. Hantraye, Novel therapies in the search for a cure for Huntington's disease, P NAS US, 98(1), 2001, pp. 3-4
Authors:
El Massioui, N
Ouary, S
Cheruel, F
Hantraye, P
Brouillet, E
Citation: N. El Massioui et al., Perseverative behavior underlying attentional set-shifting deficits in rats chronically treated with the neurotoxin 3-nitropropionic acid, EXP NEUROL, 172(1), 2001, pp. 172-181
Authors:
Mittoux, V
Joseph, JM
Conde, F
Palfi, S
Dautry, C
Poyot, T
Bloch, J
Deglon, N
Ouary, S
Nimchinsky, EA
Brouillet, E
Hof, PR
Peschanski, M
Aebischer, P
Hantraye, P
Citation: V. Mittoux et al., Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease, HUM GENE TH, 11(8), 2000, pp. 1177-1187
Authors:
Kowall, NW
Hantraye, P
Brouillet, E
Beal, MF
McKee, AC
Ferrante, RJ
Citation: Nw. Kowall et al., MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons, NEUROREPORT, 11(1), 2000, pp. 211-213
Authors:
Palfi, S
Leventhal, L
Goetz, CG
Hantraye, P
Roitberg, BZ
Sramek, J
Emborg, M
Kordower, JH
Citation: S. Palfi et al., Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeys, MOVEMENT D, 15(3), 2000, pp. 524-530
Authors:
Brouillet, E
Peschanski, M
Hantraye, P
Citation: E. Brouillet et al., Toward understanding the molecular pathology of Huntington's disease, M S-MED SCI, 16(1), 2000, pp. 57-63
Authors:
Ouary, S
Bizat, N
Altairac, S
Menetrat, H
Mittoux, V
Conde, F
Hantraye, P
Brouillet, E
Citation: S. Ouary et al., Major strain differences in response to chronic systemic administration ofthe mitochondrial toxin 3-nitropropionic acid in rats: Implications for neuroprotection studies, NEUROSCIENC, 97(3), 2000, pp. 521-530
Authors:
Dautry, W
Vaufrey, F
Brouillet, E
Bizat, N
Henry, PG
Conde, F
Bloch, G
Hantraye, P
Citation: W. Dautry et al., Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid, J CEREBR B, 20(5), 2000, pp. 789-799
Authors:
Bachoud-Levi, A
Remy, P
Nguyen, JP
Brugieres, P
Lefaucheur, JP
Bourdet, C
Baudic, S
Gaura, V
Maison, P
Haddad, B
Boisse, MF
Grandmougin, T
Jeny, R
Bartolomeo, P
Dalla Barba, G
Degos, JD
Lisovoski, F
Ergis, AM
Pailhous, E
Cesaro, P
Hantraye, P
Peschanski, M
Citation: A. Bachoud-levi et al., Motor and cognitive improvements in patients with Huntington's disease after neural transplantation, LANCET, 356(9246), 2000, pp. 1975-1979
Authors:
Kordower, JH
Emborg, ME
Bloch, J
Ma, SY
Chu, YP
Leventhal, L
McBride, J
Chen, EY
Palfi, S
Roitberg, BZ
Brown, WD
Holden, JE
Pyzalski, R
Taylor, MD
Carvey, P
Ling, ZD
Trono, D
Hantraye, P
Deglon, N
Aebischer, P
Citation: Jh. Kordower et al., Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease, SCIENCE, 290(5492), 2000, pp. 767-773
Authors:
Bachoud-Levi, AC
Bourdet, C
Brugieres, P
Nguyen, JP
Grandmougin, T
Haddad, B
Jeny, R
Bartolomeo, P
Boisse, MF
Dalla Barba, G
Degos, JD
Ergis, AM
Lefaucheur, JP
Lisovoski, F
Pailhous, E
Remy, P
Palfi, S
Defer, GL
Cesaro, P
Hantraye, P
Peschanski, M
Citation: Ac. Bachoud-levi et al., Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease, EXP NEUROL, 161(1), 2000, pp. 194-202
Authors:
Peschanski, M
Hantraye, P
Bachoud-Levi, AC
Cesaro, P
Citation: M. Peschanski et al., Therapeutic potential of fetal neural grafts in neurodegenerative diseases, B ACA N MED, 184(6), 2000, pp. 1213-1220
Authors:
Brouillet, E
Hantraye, P
Beal, MF
Citation: E. Brouillet et al., Systemic administration of 3-nitropropionic acid - A new model of Huntington's disease in rat, CONT NEUROS, 2000, pp. 301-332
Authors:
Hantraye, P
Palfi, S
Mittoux, V
Dautry, C
Conde, F
Brouillet, E
Citation: P. Hantraye et al., Replicating Huntington disease's phenotype in nonhuman primates, CONT NEUROS, 2000, pp. 333-353
Authors:
Dautry, C
Conde, F
Brouillet, E
Mittoux, V
Beal, MF
Bloch, G
Hantraye, P
Citation: C. Dautry et al., Serial 1H-NMR spectroscopy study of metabolic impairment in primates chronically treated with the succinate dehydrogenase inhibitor 3-nitropropionic acid, NEUROBIOL D, 6(4), 1999, pp. 259-268
Authors:
Remy, P
Hantraye, P
Samson, Y
Citation: P. Remy et al., Positron emission tomography, a new clinical research tool: the example ofneuronal grafts in Parkinson's disease, M S-MED SCI, 15(4), 1999, pp. 490-495
Authors:
Brouillet, E
Conde, F
Beal, MF
Hantraye, P
Citation: E. Brouillet et al., Replicating Huntington's disease phenotype in experimental animals, PROG NEUROB, 59(5), 1999, pp. 427-468
Authors:
Kordower, JH
Bloch, J
Ma, SY
Chu, YP
Palfi, S
Roitberg, BZ
Emborg, M
Hantraye, P
Deglon, N
Aebischer, P
Citation: Jh. Kordower et al., Lentiviral gene transfer to the nonhuman primate brain, EXP NEUROL, 160(1), 1999, pp. 1-16
Authors:
Ferrante, RJ
Hantraye, P
Brouillet, E
Beal, MF
Citation: Rj. Ferrante et al., Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase, BRAIN RES, 823(1-2), 1999, pp. 177-182
Risultati:
1-21
|